Hospital News and Research

RSS

Vitamin D sufficiency may be more important than high calcium intake for maintaining calcium metabolism

Calcium intake levels of more than 800 mg/day may be unnecessary for maintaining calcium metabolism if vitamin D status is adequate, according to a study in the November 9 issue of JAMA: The Journal of the American Medical Association.

10 Nov 2005

Cannabis drug provides relief from rheumatoid arthritis

According to new research, a cannabis-based drug works as a painkiller and may also slow disease progression, in rheumatoid arthritis patients.

10 Nov 2005

First study to use a cannabis-based medicine for treating rheumatoid arthritis

The first study to use a cannabis-based medicine (CBM) for treating rheumatoid arthritis has found that it has a significant effect on easing pain and on suppressing the disease.

9 Nov 2005

Urban Britain is a recipe for heart disease

Researchers at The University of Manchester’s Medical School, working with teams in India and Birmingham, have found that people moving from South Asia to the UK significantly increase their risk of contracting cardiovascular disease (CVD).

From The University of Manchester 9 Nov 2005

Vaccine for a type of blood cancer - follicular lymphoma

A team of researchers has demonstrated the clinical efficacy and benefits of a vaccine for a type of blood cancer, follicular lymphoma, amongst first time relapse patients. Specialists from two University of Navarre centres – the University Hospital and the Research Centre for Applied Medicine (CIMA) - have worked jointly since 2001 on the research.

9 Nov 2005

With adequate vitamin D extra calcium unnecessary

New research says that in order to maintain calcium metabolism, taking as much as 800 milligrams of calcium daily is probably unnecessary provided that vitamin D levels are normal.

9 Nov 2005

Relax girls - it's not the coffee that's raising your blood pressure!

According to the latest study, having a coffee drinking habit is not going to increase your blood pressure if you are a woman, but knocking back the colas is a different kettle of fish!

9 Nov 2005

Aspirin and ibuprofen may significantly reduce the risk of esophageal cancer among people with Barrett's esophagus

Aspirin and other nonsteroidal anti- inflammatory drugs, such as ibuprofen, may significantly reduce the risk of esophageal cancer among people with Barrett's esophagus, a precancerous condition associated with chronic heartburn that affects an estimated 1 million to 2 million Americans.

8 Nov 2005

Young scientists turn to gel to ease side-effects of cancer treatment

Three young scientists in the University of York’s Department of Chemistry have developed a gel that could spare cancer patients some of the unpleasant and dangerous side-effects of radiotherapy.

8 Nov 2005

Doctor facing manslaughter charges in Australia sparks calls for overhaul of U.S. regulations

An Indian-born, American-trained surgeon who is facing possible manslaughter charges in Australia, and nicknamed "Dr Death" has sparked calls for an overhaul of health regulations and a review of malpractice suits in his U.S. home state of Oregon.

8 Nov 2005

Public health service to fund live liver transplants

An announcement that new organ transplant technology will now allow adult patients to receive liver transplants from a living relative for the first time on the NHS, marks a new era in public health services.

8 Nov 2005

Xolair (omalizumab) brings new hope for severe asthma sufferers

The launch of a new drug to treat asthma has given new hope to people with severe asthma.

8 Nov 2005

Dead poultry in Saudi tested for bird flu

According to local media reports, veterinary authorities are carrying out tests in order to determine whether poultry found dead in a farm in southwestern Saudi Arabia were infected with the bird flu virus.

8 Nov 2005

Children bottle-fed past 12 months of age may be at high risk for iron deficiency

Children bottle-fed past 12 months of age and Mexican-American children may be at high risk for iron deficiency and the problems that accompany it, according to a national study by Medical College of Wisconsin and Children's Hospital of Wisconsin researchers.

7 Nov 2005

First clinical study of FX06 treatment against damage caused by heart attacks

Central to the study is FXO6, a peptide developed and patented by Austro-American company Fibrex Medical. Fibrex will now test the tolerability and pharmacokinetics of FX06 in humans. The peptide reduces inflammatory responses of the heart muscle that can arise after treatment for a myocardial infarction. Tests will begin immediately on the first - healthy - subjects at the Vienna General Hospital.

7 Nov 2005

Research project to advance understanding of how cancer cells evade the immune system

A pre-clinical research project coordinated by The University of Manchester, which will advance understanding of how cancer cells evade the immune system, has been awarded nearly 12m Euro by the EU.

From The University of Manchester 7 Nov 2005

Diagnostics test for monitoring anti-HIV drugs hits European market

The test has been acquired by Delphic Europe - a diagnostics products provider - which will develop it in conjunction with viral resistance testing for market on the continent. The service was created by Professor David Back, Dr Saye Khoo and a team in the School of Biomedical Science and is currently used to analyse blood samples from patients with HIV across the UK in order to identify the correct dosage of medicine for individual patients.

7 Nov 2005

When it comes to heart attack risk - being pear shape is better than being apple shape

New research says that a far better way of assessing a persons heart attack risk is to look at waist-to-hip ratio rather than a person's relative height and weight.

7 Nov 2005

Hormonal clue to higher asthma rates in women

According to experts hormone fluctuations resulting from life cycle changes are a factor in higher rates of asthma, more frequent emergency department visits, and higher hospital admission rates in women than in men.

7 Nov 2005

HIV antiretroviral therapy does help those in third world

With preliminary results from a study in Botswana, Harvard School of Public Health researchers have found that people with HIV-1 subtype C in resource-poor settings, who receive antiretroviral (ARV) therapy, can achieve comparable results to those in the developed world.

7 Nov 2005